Tyra Biosciences, Inc.

NASDAQ:TYRA

10.55 (USD) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 100.72191.966103.89299.49254.36658.006215.652232.413241.701251.213263.211275.107292.499302.182312.823135.204140.63815.224
Short Term Investments 218.222249.475256.238274.306128.096145.463000000000000
Cash and Short Term Investments 318.943341.441360.13373.796382.462203.469215.652232.413241.701251.213263.211275.107292.499302.182312.823135.204140.63815.224
Net Receivables 00001.50000000000000
Inventory 000000000000000000
Other Current Assets 5.6236.0225.4817.6568.31615.7048.9788.3335.0086.0758.524.3843.0523.751.3560.2170.190.057
Total Current Assets 324.566347.463365.611378.574390.778211.671224.63240.746246.709257.288267.471277.299294.025304.057313.501135.421140.82815.281
Non-Current Assets:
Property, Plant & Equipment, Net 7.4687.7197.9758.1948.0058.1547.3837.43.4723.5433.6423.7373.5842.0891.9081.9230.4670.466
Goodwill 000000000000000000
Intangible Assets 000000000000000000
Goodwill and Intangible Assets 0000000000000-0.5050000
Long Term Investments 00011111011110.2430.24300.2430
Tax Assets 00000000000000.2620000
Other Non-Current Assets 11.4428.3767.0064.6934.9585.0325.3450.8664.8744.353.8725.0820.3620.050.3182.5740.2710.264
Total Non-Current Assets 18.9116.09514.98113.88713.96314.18613.7289.2668.3468.8938.5149.8194.9462.6442.4694.4970.9810.73
Total Assets 343.476363.558380.592392.461404.741225.857238.358250.012255.055266.181275.985287.118298.971306.701315.97139.918141.80916.011
Liabilities & Equity:
Current Liabilities:
Account Payables 2.50.591.1651.5772.8794.6622.3081.441.281.1452.7472.3431.3560.5992.0681.8750.8410.664
Short Term Debt 0.4260.4120.3980.7660.370.560.2960.2880.1440.280.2540.2460.2380.4040.270.1360.0880.142
Tax Payables 000000000000000000
Deferred Revenue 000-0.38300000000000000
Other Current Liabilities 11.3213.59210.818.0395.46710.1117.5433.6772.2584.2762.4882.8663.3072.6132.431.7380.6061.052
Total Current Liabilities 14.24614.59412.37310.3828.71615.33310.1475.4053.6825.7015.4895.4554.9013.6164.7683.7491.5351.858
Non-Current Liabilities:
Long Term Debt 5.6965.815.926.0166.1176.2165.9645.9272.4442.4822.5142.5492.5830.9811.0371.09100
Deferred Revenue Non-Current 0000000000000-0.2620000
Deferred Tax Liabilities Non-Current 00000000000000.2620000
Other Non-Current Liabilities 01.5420.0110.020.0290.0460.0770.1080.1390.1690.2260.2610.3030.3670.434157.745157.79627.791
Total Non-Current Liabilities 5.6965.8135.9316.0366.1466.2626.0416.0352.5832.6512.742.812.8861.3481.471158.836157.79627.791
Total Liabilities 19.94220.40718.30416.41814.86221.59516.18811.446.2658.3528.2298.2657.7874.9646.239162.585159.33129.649
Equity:
Preferred Stock 00000000000000315.97157.274157.27427.651
Common Stock 0.0050.0050.0050.0050.0050.0040.0040.0040.0040.0040.0040.0040.0040.0040.004000
Retained Earnings -279.458-251.311-225.74-201.724-183.022-164.83-142-120.848-107.576-95.696-82.801-70.292-55.197-40.371-30.441-23.798-18.286-14.077
Accumulated Other Comprehensive Income/Loss 0.6880.771.752-0.184-0.0060.381000-0-0-000-315.97-000
Other Total Stockholders Equity 602.299593.687586.271577.946572.902368.707364.166359.416356.362353.521350.553349.141346.377342.104656.138-156.143-156.51-27.212
Total Shareholders Equity 323.534343.151362.288376.043389.879204.262222.17238.572248.79-95.696267.756278.853291.184301.737309.731-22.667-17.522-13.638
Total Equity 323.534343.151362.288376.043389.879204.262222.17238.572248.79-95.696267.756278.853291.184301.737309.731-22.667-17.522-13.638
Total Liabilities & Shareholders Equity 343.476363.558380.592392.461404.741225.857238.358250.012255.055-87.344275.985287.118298.971306.701315.97139.918141.80916.011